
US launches investigation into Germany's pharma policies over drug pricing
The U.S. has launched an investigation into Germany's pharma policies, citing "persistent underpayment" for medicines as Germany seeks to control rising healthcare costs. U.S. Trade Representative Jamieson Greer expressed concern over proposed legislation to reduce drug spending, calling it a "serious step backwards."




















